HealthCare Royalty

HealthCare Royalty (HCRx) is a leading royalty acquisition company focused on commercial or near-commercial stage biopharmaceutical products. HCRx has invested $5+ billion in more than 85 biopharma products since inception and has offices in Stamford (CT), San Francisco, Boston and London. The HCRx team consists of 33 individuals (including our Senior Advisors), including former pharmaceutical executives, scientists, physicians, bankers, research analysts and consultants. Our philosophy is simple - We are asset-focused investors seeking to identify compelling investment opportunities that will generate long-term value. We target healthcare assets with significant clinical value and strong barriers to entry that are meaningful to...

Private equity,growth capital,healthcare royalty financing,pharmaceuticals,biotechnology,specialty pharmaceuticals,medical devices/diagnostics,and non-dilutive financing

Healthcare royalty operates in the Investment management industry.

Healthcare royalty's revenue is 11m - 100m

Healthcare royalty has 11 - 50 employees.